Grade IV Astrocytoma: Clinical Trials

8 trials for Grade IV Astrocytoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 active not recruiting, 1 recruiting, 1 terminated. 5 Phase 1, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 15Active not recruiting 2, Completed 1, Recruiting 1, Terminated 1
Phase 23Completed 2, Recruiting 1
Phase 31Unknown 1

Follow Grade IV Astrocytoma: new trials by email Literature Review of Grade IV Astrocytoma trials Research Report on Grade IV Astrocytoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
LMP744, Conventional Surgery or Biopsy - Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Phase 1 / Phase 2RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)402026-07-152026-10-16
Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma
exHSC, Nivolumab, Resection or biopsy - Recurrent High-grade Glioma, Grade III Astrocytoma
Phase 1Active not recruitingUniversity of Florida122025-07-252026-09-23
Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
Tadalafil - Grade III Astrocytoma, Grade IV Astrocytoma
Phase 1CompletedWashington University School of Medicine182021-05-142023-06-13
Surgical Nivolumab And Ipilimumab For Recurrent GBM
Nivolumab-Placebo, Nivolumab, Ipilimumab-Placebo - Glioblastoma, GBM
Phase 1Active not recruitingGilbert Youssef632021-02-012026-10-19
Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma
MDNA55 - Glioblastoma, Grade IV Astrocytoma
Phase 2CompletedMedicenna Therapeutics, Inc.472017-04-112022-10-24
Phase-1 Study of Folinic Acid to Modulate MGMT Gene in Glioblastoma
Temozolomide, folinic acid at pharmacological dose is the escalated drug, High voltage radiation therapy (linear accelerator) - Grade IV Astrocytoma, Glioblastoma
Phase 1TerminatedInstitut Cancerologie de l'Ouest242013-01-012023-02-21
Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
TVI-Brain-1 - Grade IV Glioma, Grade IV Astrocytoma
Phase 2CompletedTVAX Biomedical142011-06-012023-07-03
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Dendritic cell immunotherapy - Glioblastoma Multiforme, Glioblastoma
Phase 3UnknownNorthwest Biotherapeutics3482006-12-012022-05-18

Narrower conditions

Glioblastoma (8)  ·  Glioma (6)  ·  Brain Neoplasms (4)  ·  Astrocytoma (3)  ·  Neoplasms (3)  ·  Central Nervous System Neoplasms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Ependymoma (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Oligodendroglioma (1)  ·  Recurrence (1)

Broader conditions

Neoplasms, Germ Cell and Embryonal (8)  ·  Neoplasms, Glandular and Epithelial (8)  ·  Neoplasms, Neuroepithelial (8)  ·  Neuroectodermal Tumors (8)  ·  Neoplasms by Histologic Type (7)  ·  Neoplasms, Nerve Tissue (7)  ·  Astrocytoma (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Central Nervous System Neoplasms (2)  ·  Glioma (2)

Interventions

Biopsy (2)  ·  Nivolumab (2)  ·  Adjuvants, Immunologic (1)  ·  Cancer Vaccines (1)  ·  Ipilimumab (1)  ·  Particle Accelerators (1)  ·  Surgical Procedures, Operative (1)  ·  Tadalafil (1)  ·  Temozolomide (1)  ·  interleukin-4-Pseudomonas exotoxin (1)

Sponsors

Gilbert Youssef (1)  ·  Institut Cancerologie de l'Ouest (1)  ·  Medicenna Therapeutics, Inc. (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Northwest Biotherapeutics (1)  ·  TVAX Biomedical (1)  ·  University of Florida (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Gary Wood, Ph.D. (1)  ·  Gilbert Youssef, MD (1)  ·  Jiayi Huang, M.D. (1)  ·  John Ligon, MD (1)  ·  Linda Liau, M.D. (1)  ·  Marnix L. Bosch, MBA, PhD (1)  ·  Sadhana Jackson, M.D. (1)

Results publications

PMID 23545055, PMID 29843811, PMID 33863808, PMID 36394838, PMID 36640127